News

Abbott Labs’ surprise guidance bump is a major positive for its shareholders

  •  

An Abbott Labs employee gets the BinaxNOW rapid Covid-19 antigen test at her workplace.

Abbott Labs

Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016.


This article was originally published on CNBC